4th Jan 2005 17:10
GlaxoSmithKline PLC04 January 2005 Directors' Interests I give below details of changes in the directors' interests in the OrdinaryShares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 31 December 2004, the following Non-Executive Directors were provisionallyallocated the following awards over Ordinary Shares and American DepositoryShares (ADS's) in the Company through the Annual Re-investment of Dividends paidthroughout 2004, as listed below: SmithKline Beecham Non-Executive Directors Retainer Fee and Share AllocationAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price Shares ($) Sir Christopher Hogg 34.848 12.22Sir Ian Prosser 34.848 12.22Dr Lucy Shapiro 56.623 12.22 16.007 47.41 GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected ShareAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) No. of ADS's Average Price Shares ($) Sir Christopher Hogg 1,033.638 12.22Sir Christopher Gent 3.562 12.22Mr Lawrence Culp 44.205 47.41Mr Crispin Davis 103.034 12.22Sir Peter Job 451.575 12.22Sir Ian Prosser 294.489 12.22Dr Ronaldo Schmitz 278.007 12.22Dr Lucy Shapiro 28.731 47.41Sir Robert Wilson 10.775 12.22 The Company and the directors were informed of these allocations on 4 January2005. S M BicknellCompany Secretary4 January 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline